Proxy Battle - Xconomy

by in

Entry	Author	Date	Location
Cypress Bio Rejects Buyout Again, Calls Offer Opportunistic, Undervalued	Bruce V. Bigelow	09/28/10	San Diego
In Appeal to Cypress Bio Stockholders, Ramius Raises Buyout Offer	Bruce V. Bigelow	09/15/10	San Diego
Ramius Group Gains Ally in Fight With Cypress Bioscience	Bruce V. Bigelow	09/10/10	San Diego
Cypress Bio Acquires Technologies in Separate Deals with Marina Biotech, Alexza Pharmaceutical	Bruce V. Bigelow	08/26/10	San Diego
Icahn Calls Genzyme’s Manufacturing “Broken,” Advises Against Termeer’s Re-Election to Board	Ryan McBride	05/04/10	Boston
Agreement Between Genzyme and San Diego Activist Shareholder Suggests Truce	Bruce V. Bigelow	01/07/10	San Diego
Biogen Prepared for Proxy Battle for Facet Biotech	Ryan McBride	12/15/09	Boston
Former Novartis CEO Elected as Amylin Chairman	Bruce V. Bigelow	08/25/09	San Diego
No Peace Between Amylin and Icahn	Juha-Pekka Tikka	04/22/09	San Diego
Page 1 of 1

Xconomy National